MelaRisk

This tool is meant to be used only by medical professionals. The available tool is Mela3A, developed to provide
5-year cumulative incidence of recurrence after a diagnosis of melanoma staged IlIA. The user should be aware of the following limitations:
- the model applies only to adults (>=
18 yrs) who are surgically treated with curative intent for their primary tumor within or outside referral centers;
- the model does not apply to patients
with Melanoma at a stage different
from the IlIA;
- the covariates derived from clinical and pathological examination and not
from the preoperative biopsy;
- the model does not distinguish between local, regional or distant recurrences.